Regulatory Science: FDA Gets Help From NIH, But Is It Enough?
Executive Summary
The Food and Drug Administration is turning to the National Institutes of Health in its quest for fresh intellectual firepower to keep its regulatory science upgrade program moving ahead. [Editor's note: This story, including the headline, has been modified to correct figures related to funding for the Critical Path initiative.
You may also be interested in...
With Federal Dollars Scarce, FDA May Fundraise For Regulatory Science Initiative
Industry and other federal agencies could end up helping fund Commissioner Margaret Hamburg’s Regulatory Science Initiative, as FDA searches for money outside the appropriations process.
With Federal Dollars Scarce, FDA May Fundraise For Regulatory Science Initiative
Industry and other federal agencies could end up helping fund Commissioner Margaret Hamburg’s Regulatory Science Initiative, as FDA searches for money outside the appropriations process.